About Megalabs
Megalabs is a company based in Canelones (Uruguay) founded in 2003. Megalabs has raised $30 million across 2 funding rounds from investors including Tangent Works, Dragonfly Capital and Figment Capital. Megalabs has completed 2 acquisitions, including DS Laboratories and FRISKA. Megalabs offers products and services including Bioequivalents and Acid Hialurónico.
- Headquarter Canelones, Uruguay
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$30 M (USD)
in 2 rounds
-
Latest Funding Round
$10 M (USD), Seed
Dec 13, 2024
-
Investors
Tangent Works
& 5 more
-
Employee Count
Not available
-
Investments & Acquisitions
DS Laboratories
& 1 more
-
Acquired by
(Apr 24, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Megalabs
Megalabs offers a comprehensive portfolio of products and services, including Bioequivalents and Acid Hialurónico.
Develops generic equivalents of branded drugs for affordable access
Provides intraarticular solutions for joint health applications
People of Megalabs
Unlock access to complete
Unlock access to complete
Funding Insights of Megalabs
Megalabs has successfully raised a total of $30M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $10 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Megalabs
Megalabs has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Tangent Works, Dragonfly Capital and Figment Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward web3 sectors.
|
Locked | Locked | Locked | |
|
Venture capital fund investing in blockchain startups
|
Locked | Locked | Locked | |
|
Robot Ventures is associated with technology or robotics.
|
Locked | Locked | Locked |
Investor details for Megalabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Megalabs
Megalabs has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include DS Laboratories and FRISKA.
Investment portfolio details for Megalabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of nutritional supplements for multiple health ailments
|
Locked | Locked | 2018 | Locked | |
|
Science-backed hair and skin care products are developed.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Megalabs
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Megalabs
Detailed financials for Megalabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Megalabs Comparisons
Peer comparison for Megalabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Megalabs
Detailed competitors of Megalabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Megalabs
Complete news archive for Megalabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Megalabs
Megalabs was founded in 2003 and raised its 1st funding round 21 years after it was founded.
Megalabs is headquartered in Canelones, Uruguay. It is registered at Canelones, Canelones, Uruguay.
Megalabs is a funded company, having raised a total of $30M across 2 funding rounds to date.
Megalabs was founded in 2003 in Canelones, Uruguay, and operates within the pharmaceutical sector. A broad portfolio of medications and health solutions is manufactured and supplied internationally through its global domain. Focus is placed on research, development, and commercialization of diversified pharmaceutical offerings, with operations centered in Latin America and extending to various markets worldwide.
Megalabs offers Bioequivalents and Acid Hialurónico.
Megalabs has made 2 acquisitions, including DS Laboratories, and FRISKA.
Megalabs has 6 investors. Key investors include Tangent Works, Dragonfly Capital, Figment Capital, Folius Ventures, and Robot Ventures.